NCT05177406View on ClinicalTrials.gov

Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data

CompletedOBSERVATIONAL
Enrollment

1,839

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Migraine
Interventions
OTHER

Aimovig

patients newly initiating Aimovig therapy

Trial Locations (1)

07936-1080

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY